PDFファイル
Contents
1. SCC SCC 2 1 22. E TOSOH II SCC 100 ux L 25 x L 37 C 10 B F 363 nm 447 nm
3. 10 2 SCC 1 EIA IEMA SCC SCC
4. 3 6 1 1 E TOSOH II SCC 1 FU 1 0 nmol L s 8 10 11 12 13 E TOSOH II SCC E TOSOH II SCC E TOSOH TII SUB II E TOSOH I E TOSOH II SCC HAMA Human Anti Mouse Antibody
5. B F 4 4 SCC 1 4 2 8 C 7 7 20 C 60 2 8 C 15 25 C
6. 15 25 C 72 15 25 C 1 8 2 8 C 9 2 8 C 90 E TOSOH TII 1 2 5 L 15 25 C 30 E TOSOH II 1 5 L 15 25 C 30 2 1 2 3 1 6
7. FU A B C A 2 FU nmol L s 2 B 1 FU nmol L s 121 C 20 C 2 SCC ng mL 3 2 SCC 3 1 0 4 0 ng mL 10 40 ng mL 41 100 ng mL 2 1 2 8 C 100 20 2 12 2 SCC B TOSOH II SCC
8. SCC SCC SCC 3 Es TOSOH II SCC 5 SCC 3 1 0 4 0 ng mL 10 40 ng mL 41 100 ng AD 100 mL 5 15 4 0 1 100 ng mL 0 1 ng mL 1 6 1 1 FU 2 x SD 5 2E TOSOH II SCC 1 0 mL x2 DS 2 6 5 000 ng mL 1 0 mL x2 E TOSOH II SCC 5 0 O PL 224 1 y
9. 95 2 0 ng mL 2 1 2 3 SI SCC ng mL SI gL g SCC L ng SCC mL x 1 0 SCC 45 000 7 2 SCC
10. SCC 90 100 ng mL 1 5 AIA 2000 Dalbrator Lat 2008005108120000 0 10 0 9 0 50 0 0 80 90 100 10 Gone 1 1 2 3 E TOSOH II SCC SCC 241 SCC
11. 1 4 5 6 E TOSOH TII SCC SCC SCC BE TOSOH TII SUB II 1 E TOSOH II 4 2 E TOSOH II BE TOSOH II SCC TOSOH TI TOSOH II TOSOH II TOSOH II 2 3 4 5 6 E E E E SCC SCC SCC SCC E TOSOH II SCC E TOSOH II SCC E TOSOH II SCC E TOSOH I E TOSOH I 1 1 2 3 4 5 SCC SCC 1 EIA IEMA
12. E TOSOH TII SCC 550 mg dL 21 mg dL 22 mg dL 1 600 mg dL 5 g dL 20 mg dL Na 100 U mL 2 8 C 15 25 C 1 1 2 3 4 5 E TOSOH II SCC 15 25 C 168 1 15 25 C 8 2 8 C 16
13. 21 2 8 C 30 E TOSOH II 1 E TOSOHI II 1 100 mL 15 25 C 3 2 8 C 30 E TOSOH II SCC 1 E TOSOH II SCC 2 6 1 0 mL 2 8 C 1 E TOSOH II SCC E TOSOH II SCC
14. 5 2 8 C 7 7 20 C 60 6 Rs 252 1123 2743 1 0120 17 1200 TEL 0467 76 5384 FAX 0467 79 2550 TosoH 3 8 2 TEL 03 5427 5181 FAX 03 5427 5220 gt TosoH 2 9 FUJIREBIO Diagnostics Inc
15. HIV HBV HCV 2 E TOSOH TT SCC 1 B TOSOH II SCC 2 0 5 2 0 ng mL FU SCC FU 1 3 1 0 nmol L s ng mL 1 1 FU
16. in cancer of the uterine cervix Tumor Biol 19 505 516 1998 2 5 Snyderman CH et al A reappraisal of the sduamous cell carcinoma antigen as a tumor marker in head and neck cancer Arch Otolaryngol Head Neck Surg 121 1294 1297 1995 6 Vassilakopoulos T et al Diagnostic and prognostic significance of squamous 3 cell carcinoma antigen in non small cell lung cancer Lung Cancer 32 137 144 2001 4 90 90
17. A IRMA x E TOSOH II y 0 9x 0 1 0015968 E TOSOH II 100 mL x2 r 0 98 E TOSOH II 100mL x2 n 289 r y 2 y B CHIA lt 5985 TOSOH I 0015956 E TOSOH I 100 mL x4 y 0 9x 0 1 r 0 97 n 379 l Kato H et al Radioimmunoassay for Tumor Antigen of Human Cervical 3 y x Squamous Cell Carcinoma Cancer 40 1621 1628 1977 2 Suminami Y et al Squamous cell carcinoma antigen is a new member of y 1 0x 0 1 the serine protease inhibitors Biochem Biophys Res Commun 181 51 58 r 1 0 1991 n 152 3 Micke O et al The impact of squamous cell carcinoma SCC antigen in the follow up after radiotherapy in patients with cervical cancer Anticancer Res 20 6D 5113 5115 2000 1 4 de Bruijn HW et al The clinical value of squamous cell carcinoma antigen 1
18. 1008071001 055B 2015 5 2 2013 10 1 22500AMX01827000 S CC E TOSOH IT SCC EIA SCC nawre SCC SCC
Download Pdf Manuals
Related Search